SGLT2 inhibitor Dapagliflozin alleviates cardiac dysfunction and fibrosis after myocardial infarction by activating PXR and promoting angiogenesis
| Autor: | Wang, Min, Liu, Xiameng, Ding, Bo, Lu, Qiulun, Ma, Jianhua |
|---|---|
| Zdroj: | In Biomedicine & Pharmacotherapy August 2024 177 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect